Categories Analysis, Consumer

What to expect when Philip Morris (PM) reports Q3 2023 earnings

Philip Morris has guided for adjusted EPS to range between $1.60-1.65 in Q3 2023

Shares of Philip Morris International Inc. (NYSE: PM) stayed green on Monday. The stock has dropped 8% year-to-date and 6% over the past three months. The tobacco giant is slated to report its third quarter 2023 earnings results on Thursday, October 19, before market open. Here’s a look at what to expect from the earnings report:

Revenue

Analysts are projecting revenue of $9.2 billion for PMI in Q3 2023, which represents a growth of 15% from the same period a year ago. In the second quarter of 2023, revenues increased 14.5% to $9 billion.

Earnings

Philip Morris has guided for adjusted EPS to range between $1.60-1.65 in Q3 2023. Analysts are predicting EPS of $1.61, which compares to adjusted EPS of $1.53 reported in the prior-year period. In Q2 2023, adjusted EPS increased 17% to $1.60.

Points to note

In the second quarter, PMI’s top line benefited from higher pricing and heated tobacco unit (HTU) shipment volume growth. HTU shipments increased 26.6% in Q2. However, cigarette shipments continue to decline with the company seeing a drop of 0.4% last quarter. The company has forecasted HTU shipment volume of around 31-33 billion units in the third quarter of 2023.

The momentum in HTUs is led by strength in IQOS, which was estimated to have 27.2 million users at the end of the second quarter. Philip Morris is seeing strong gains for IQOS in developed countries along with encouraging growth in low and middle-income markets.

The Swedish Match acquisition has helped boost PMI’s oral product shipment volume. In Q2, oral product shipment volume jumped over 100%, reflecting growth in nicotine pouches. ZYN nicotine pouches saw volume growth of over 50% in the US in Q2.

Philip Morris is making strong progress on its smoke-free transformation. Led by IQOS and ZYN, smoke-free products made up 35% of its adjusted net revenues in the first half of 2023. This momentum is likely to continue in the second half as well, benefiting Q3 results.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted

Unicycive is all-in on kidney care, focusing on underserved areas: CEO

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with renal diseases. In an email interview with AlphaStreet, CEO Dr.

Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for

Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top